Understanding how prenatal alcohol exposure disrupts normal brain development could revolutionize prevention strategies for one of the most preventable causes of intellectual disability. Current approaches focus on behavioral interventions, but emerging molecular insights suggest more targeted therapeutic opportunities may exist.
This comprehensive analysis of 36 experimental studies identified 241 differentially expressed microRNAs following prenatal ethanol exposure, with seven showing consistent alterations across diverse experimental conditions: miR-9, miR-335, miR-15b, miR-34a, let-7i, miR-200a, and miR-326. These small regulatory RNA molecules control critical developmental processes including programmed cell death, neural pathway formation, and cellular migration. Specific microRNAs like miR-335 and miR-21 emerged as key players in apoptosis regulation, while miR-17-5p and various let-7 family members influence axon guidance—the process by which developing neurons form proper connections.
The convergence on these seven microRNAs despite substantial methodological diversity across studies strengthens their potential significance as biomarkers or therapeutic targets. However, the field faces significant challenges in translating these findings. The reviewed studies employed vastly different alcohol concentrations, exposure timing, and model systems, making direct comparisons difficult. Most research remains confined to animal models, leaving questions about human relevance unanswered. Additionally, microRNA regulation represents just one layer of the complex molecular cascade triggered by prenatal alcohol exposure. While these findings advance our mechanistic understanding of fetal alcohol spectrum disorders, considerable work remains before molecular insights can inform clinical practice or preventive interventions.